Whitney tackles the most challenging legal issues at the intersection of government investigations and class actions for Fortune 500 companies.
Prior to joining DLA Piper, Whitney was a federal prosecutor and Chief of Appeals; in that capacity she successfully tried complex suits involving financial crimes, and she briefed and argued multiple appeals before the Third Circuit. She leverages her prior government experience to evaluate regulatory authority and minimize the effects of government action on multi-party suits.
Through her significant trial and appellate experience, Whitney understands how and when to litigate, and she enjoys working with clients to develop overarching litigation strategies that fit their complex business needs. Whitney's focus on internalizing her client's strategic goals and situating those within the developing legal landscape spreads across multiple issues, including ESG-related mass tort suits, antitrust conspiracy allegations, and novel regulatory disputes.
Recent Representations Include:
- A global pharmaceutical manufacturer defending antitrust allegations brought by state Attorneys General and private classes in multi-party litigation in the Eastern District of Pennsylvania.
- A hospitality industry client facing state law negligence claims and federal statutory actions for ESG-related issues across the country.
- A telecommunications client in multiparty litigation over ESG-related issues in state court.
- A financial services industry client contesting multi-party lawsuits stemming from third-party fraud in New York.
- Multiple clients seeking advice on state criminal and civil liability relating to reproductive choices post-Dobbs.
- Technology industry associations exploring First Amendment and Communications Decency Act arguments against state Attorneys General.
- An innovative biotech provider in a complex contract dispute involving preemption, federal jurisdiction, and administrative exhaustion arguments in the Northern District of Texas.
- Multiple pharmaceutical manufacturers exploring preemption arguments arising from the FDA approval process against false claims and product liability suits.
- Various clients evaluating options to contest state and federal criminal subpoenas.
- Social justice and military experts in a pro bono amicus capacity before the U.S. Supreme Court, circuit courts, and federal district courts championing expansion of individuals' access to justice and voting rights.
- J.D., Yale Law School
- B.A., Georgetown University
- Hon. Debra Ann Livingston, U.S. Court of Appeals for the Second Circuit
My latest insights
Life sciences companies and the risks posed by the mifepristone litigation
19 May 2023 .1 minute read
The Fifth Circuit’s partial stay to the mifepristone order grants partial relief, but...
14 April 2023 .5 minute read